Mrv0541 02231218162D 18 19 0 0 1 0 999 V2000 1.6500 -1.3578 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 4.3826 -1.0607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8177 -2.5127 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.4331 -2.4265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.2863 0.2492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.7152 0.2492 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0007 1.4868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7152 2.7243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.1277 -1.8453 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.3027 -1.8453 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.7152 -0.5758 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.0478 -1.0607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6126 -2.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2631 -0.8057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4296 0.6617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0007 0.6617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4296 1.4868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7152 1.8993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 14 1 0 0 0 0 2 9 1 0 0 0 0 2 11 1 0 0 0 0 10 3 1 1 0 0 0 4 13 1 0 0 0 0 5 16 2 0 0 0 0 11 6 1 6 0 0 0 6 15 1 0 0 0 0 6 16 1 0 0 0 0 7 16 1 0 0 0 0 7 18 2 0 0 0 0 8 18 1 0 0 0 0 9 10 1 0 0 0 0 9 13 1 6 0 0 0 10 12 1 0 0 0 0 11 12 1 0 0 0 0 12 14 2 0 0 0 0 15 17 2 0 0 0 0 17 18 1 0 0 0 0 M END > DB06433 > drugbank > NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)\C1=C/F > InChI=1S/C10H12FN3O4/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17/h1-3,6,8-9,15-16H,4H2,(H2,12,13,17)/b5-3+/t6-,8+,9-/m1/s1 > GFFXZLZWLOBBLO-ASKVSEFXSA-N > C10H12FN3O4 > 257.2184 > 257.081184092 > 6 > 30 > 0.0009503781780250195 > 23.050807473028485 > 1 > 3 > 0 > 0 > 4-amino-1-[(2R,3E,4S,5R)-3-(fluoromethylidene)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one > -1.22 > -1.927385605 > -1.90 > 0 > 0 > 2 > 0 > 14.700558475354157 > 13.27733150565886 > 3.978559913420981 > 108.37999999999998 > 57.72260000000001 > 2 > 1 > 3.27e+00 g/l > biotin > 0 > DB06433 > investigational > Tezacitabine > 2'-Deoxy-2'-(fluoromethylene)cytidine; Tezacitabine > Tezacitabine monohydrate $$$$